Zevra Therapeutics (ZVRA) Shares Outstanding (2014 - 2026)
Zevra Therapeutics' Shares Outstanding was 59.16 million in Q2 2026, up 8.0% from 54.78 million a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Zevra Therapeutics came in at 55.31 million, up 19.6% from FY2024.
- Shares Outstanding has now increased for three consecutive years, with a five-year compound annual growth rate of 47.4% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 46.25 million in FY2024 (+30.5%), 35.45 million in FY2023 (+2.8%), 34.49 million in FY2022 (-42.1%) and 59.53 million in FY2021 (+647.7%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding since Q3 2022.
- Compared with a year earlier, Shares Outstanding has increased for 11 straight quarters, with growth averaging 22.6% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding over five years was Q3 2021 (growth of 695.8%); the worst was Q2 2023 (a decline of 50.8%).
- Per Business Quant data, ZVRA's Shares Outstanding in the three quarters before Q2 2026 was 58.41 million (Q1 2026), 55.31 million (Q4 2025) and 55.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 59.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.16 Mn |
| Mar 31, 2026 | 58.41 Mn |
| Dec 31, 2025 | 55.31 Mn |
| Sep 30, 2025 | 55.95 Mn |
| Jun 30, 2025 | 54.78 Mn |
| Mar 31, 2025 | 54.10 Mn |
| Dec 31, 2024 | 46.25 Mn |
| Sep 30, 2024 | 47.81 Mn |
| Jun 30, 2024 | 41.90 Mn |
| Mar 31, 2024 | 41.78 Mn |
| Dec 31, 2023 | 35.45 Mn |
| Sep 30, 2023 | 34.73 Mn |
| Jun 30, 2023 | 33.90 Mn |
| Mar 31, 2023 | 34.47 Mn |
| Dec 31, 2022 | 34.49 Mn |
| Sep 30, 2022 | 68.99 Mn |
| Jun 30, 2022 | 68.89 Mn |
| Mar 31, 2022 | 69.01 Mn |
| Dec 31, 2021 | 59.53 Mn |
| Sep 30, 2021 | 70.44 Mn |
API Access
Zevra Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();